Novartis nabs U.S. approval to buy Fougera; J&J files for new Simponi use in colitis;

 @FiercePharma: J&J's ‪pharma‬ sales up slightly, thanks to int'l growth of 6.8%; US down 4.5% on Doxil shortage, Levaquin generics. Release | Follow @FiercePharma

> Novartis ($NVS) won U.S. approval to buy the dermatology drugmaker Fougera, provided it give up rights to market several skin medicines made by Tolmar. Item

> Johnson & Johnson's ($JNJ) Janssen unit asked U.S. and European regulators to approve a new use in ulcerative colitis for its anfi-inflammatory drug Simponi. Release

> Watson Pharmaceuticals ($WPI) settled wholesale-pricing allegations in the state of Idaho for $1.7 million. Report

> A rebound in pharmaceutical exports pushed Singapore's overall foreign trade numbers upward. More

> A small roof fire at Merck's ($MRK) West Point plant caused an evacuation Sunday but no injuries; the cause remains under investigation. Report

Biotech News

 @FierceBiotech: DeCode, Genentech find gene mutation marks protection against ‪Alzheimer's‬. More | Follow @FierceBiotech

 @JohnCFierce: Elan is priced for a buyout deal? Oh, my. Who would buy that company just now? Report | Follow @JohnCFierce

 @RyanMFierce: Alnylam up 45% after ALN-TTR02 passes Phase I. Could this be the RNAi drug we've all been waiting for? | Follow @RyanMFierce

> Investors on high alert as D-Day arrives for Vivus's Qnexa. Article

> AZ's MedImmune axing 200 in California R&D restructuring. News

Medical Device News

@FierceMedDev: Radiology devicemaker Accuray is buying Morhpormics for $5.7M. Release | Follow @FierceMedDev

@DamianFierce: Biomet has cut back its year-over-year losses due to sales growth in its major divisions. More | Follow @DamianFierce

> Life Technologies expands its Dx business with Navigenics buy. News

> J&J posts flat device sales for Q2. Article

> Ex-Medtronic CEO pulled down $8M in 2012. Story

Pharma Manufacturing News

> Lonza seeks growth in China after securing IP. Story

> Feds get conviction in fake J&J test strips case. More

> India regulator orders Aurobindo, others to close 12 plants. Report

> Hospira blames supplier's bad vials for latest recall. Article

Biotech Research News

> Researchers use gene therapy to treat spinal muscular atrophy. Article

> New 'molecular grenade' used to attack tumor cells. Report

> Researcher rebuts rival finding that ovarian stem cells exist. Story

> Rare gene mutation protects against Alzheimer's. More

> Alnylam generates preclinical buzz with RNAi hemophilia drug. News

And Finally... Doctors prefer doing work-related research online, rather than in print, a study funded by Google found. Report